The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough.
On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient form of pre-exposure prophylaxis (PrEP). In clinical trials, the drug was shown to be…